Integrating personalized skin cancer risk feedback into community health centers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This hybrid effectiveness-implementation project compares a precision prevention booklet that incorporates MC1R genetic risk information to a standard prevention booklet among adult patients at six Tampa Family Health Centers. Participants complete a baseline questionnaire, provide a saliva sample for MC1R genotyping, and receive one of the two prevention booklets tailored by language (English or Spanish). The study measures uptake of skin cancer prevention behaviors and examines how different messages about risk affect those behaviors and the feasibility of delivering genetic risk feedback in a safety-net setting. Outcomes will inform whether integrating personalized genetic and behavioral risk information is acceptable and effective in federally qualified health centers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
* Be 18 years of age or older.
* Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
* Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
* Be able to provide informed consent (written or electronic).
* Prefer English or Spanish for communication and study materials.

Exclusion Criteria:

* Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
* Are unwilling or unable to complete the baseline assessment or return the saliva kit.
* Decline to provide informed consent.
* Are under 18 years of age.

Where it's running

• Moffitt Cancer Center
  Tampa, Florida, United States Recruiting
• Memorial Sloan Kettering Cancer Center
  New York, New York, United States Active not recruiting

Study contacts

• Principal investigator: Peter Kanetsky, PhD, MPH — Moffitt Cancer Center
• Study coordinator: Rania Abdulla
• Email: Rania.Abdulla@moffitt.org
• Phone: 813-745-6813

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Psycho-physiological profiling of people with low versus high heat resilience

  This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.

  Recruiting at 2 sites University of Thessaly · Copenhagen and 1 other locations · NCT07510061

• Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers

  This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.

  Recruiting at 2 sites Phase 4 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07426484

• First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia

  This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07422779

• Optical and multi-modal analysis to help diagnose skin cancer

  This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.

  Recruiting Centre Hospitalier Régional Metz-Thionville · Metz · NCT07406022

• Early skin tumor detection with telemedicine in primary care

  This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.

  Recruiting at 2 sites Institute of Health Information and Statistics of the Czech Republic · Brno and 4 other locations · NCT07349940

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.